INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
RN
Robuck Richard NEVP, CFO and Treasurer
CHRDChord Energy Corp
Grant or award
A—
2,769 sh
Jan 23, 2026Jan 26, 2026
Page 1398 of 1786
← PrevNext →
traded Jan 23, 2026
+3d
SEC Form 4

Evidence

17
BE
Brown Daniel EDirector, President and CEO
CHRDChord Energy Corp
Grant or award
A—
7,017 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
AP
Ahlstrom PaulDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
RH
Resch Martin H.President & CEO
CASSCASS INFORMATION SYSTEMS INC
Grant or award
A—
8,413 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
KJ
Kroll Lara JSVP & Chief Accounting Officer
CHRDChord Energy Corp
Grant or award
A—
3,170 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
VR
Vazquez RaulDirector
INTUINTUIT INC.
Option exercise
M—
347 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
NT
Nguyen Trang TDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
GM
Gass MichelleDirector, President & CEO
LEVILEVI STRAUSS & CO
Grant or award
A—
225.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
PK
Pinson KimberlyChief Financial Officer
INTZINTRUSION INC
Tax withholding
F$14K
11.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
KJ
Kroll Lara JSVP & Chief Accounting Officer
CHRDChord Energy Corp
Grant or award
A—
634 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Grant or award
A—
21.1K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
CR
Camden Andrew RossPresident
UMACUnusual Machines, Inc.
Grant or award
A—
110.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
AK
Ambrose KristenSVP & Chief Accounting Officer
VRTXVERTEX PHARMACEUTICALS INC / MA
Grant or award
A—
2,950 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
RN
Robuck Richard NEVP, CFO and Treasurer
CHRDChord Energy Corp
Grant or award
A—
11.1K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

16
HJ
Henke Darrin J.EVP and COO
CHRDChord Energy Corp
Tax withholding
F$103K
1,085 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

16
HF
Heilbronn FrancoisDirector
IPARINTERPARFUMS INC
Option exercise
M$93K
1,500 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.70M
632.9K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

16
CR
Chen RosemarieDirector
DCOMDime Commercial Bancshares, Inc. /NY/
Gift
G—
1,449 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

16
KB
Kinney Shannon BrowningEVP, CAO, GC & Corp Secretary
CHRDChord Energy Corp
Tax withholding
F$76K
794 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

16
LS
Levy Richard SDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise
M$66K
4,000 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.71M
632.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

15
KN
Kroeker NathanCCO and Interim CFO
EOSEEos Energy Enterprises, Inc.
Open-market sale · 10b5-1 plan
SELL$802K
50.0K sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

15
LT
Lin Chih-Hsiang (Thompson)Director, President and CEO
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$381K
9,932 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
NJ
Normile Michael JamesCFO
CASSCASS INFORMATION SYSTEMS INC
Grant or award
A—
2,836 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
JJ
Jarrett JenniferChief Operating Officer
RCUSArcus Biosciences, Inc.
Grant or award
A—
31.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

13
HJ
Head T JoeChief Technology Officer
INTZINTRUSION INC
Tax withholding
F$14K
11.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
WB
Willoughby Scott B.SVP, CHIEF LEGAL OFFICER, SECY
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$15K
36.7K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
MS
Macrae SandyDirector, PRESIDENT, CEO AND DIRECTOR
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$41K
103.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
LK
Liljenquist KatieDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

13
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$15K
669 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
DN
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$15K
36.7K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
ED
Erdbruegger Dwight DPresident
CASSCASS INFORMATION SYSTEMS INC
Grant or award
A—
2,318 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
SJ
Szkutak Thomas JDirector
INTUINTUIT INC.
Option exercise
M—
694 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
SS
Schuckman Matthew StevenExecutive Vice President
CASSCASS INFORMATION SYSTEMS INC
Grant or award
A—
1,992 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

13
DP
Duraibabu PrathyushaPRINCIPAL FINANCIAL OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$15K
36.7K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence